3588-56-5

Basic information

• Product Name: N-[(phenylmethoxy)carbonyl]-D-aspartic acid,1,1-dimethylethyl ester
• Synonyms: N-[(phenylmethoxy)carbonyl]-D-aspartic acid,1,1-dimethylethyl ester
• CAS NO: 3588-56-5
• Molecular Weight: 323.346
• Mol File: 3588-56-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[(phenylmethoxy)carbonyl]-D-aspartic acid,1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N-[(phenylmethoxy)carbonyl]-D-aspartic acid,1,1-dimethylethyl ester(3588-56-5)
• EPA Substance Registry System: N-[(phenylmethoxy)carbonyl]-D-aspartic acid,1,1-dimethylethyl ester(3588-56-5)

Safety Data

• Hazardous Substances Data: 3588-56-5(Hazardous Substances Data)

Upstream product

• 149967-06-6 N-<(phenylmethoxy)carbonyl>-D-aspartic acid, 1-(1,1-dimethylethyl) 4-methyl ester 

Downstream Products

• 17543-17-8 Benzyloxycarbonyl-asparaginsaeure-α-p-nitrophenylester-β-tert.butylester 
• 41088-85-1 N-[(phenylmethoxy)carbonyl]-D-homoserine 
• 1187648-24-3 tert-butyl 3-amino-3-(3-chloro-6-(4-(methoxycarbonylamino)phenyl)pyridazin-4-yl)propanoate 
• 1359015-29-4 (E)-benzyl N-(2-tert-butoxycarbonylethenyl)carbamate 
• 1578252-33-1 benzyl N-[2-tert-butoxycarbonyl-1-(p-toluenesulfonyl)ethyl]carbamate 
• 188890-84-8 3-benzyloxycarbonylamino-5-bromo-4-oxopentanoic acid 1,1-dimethylethyl ester 
• 232596-54-2 tert-butyl (S)-2-(2-benzyloxycarbonylamino-3-tert-butoxycarbonyl-propionylamino)-benzoate 
• 147395-39-9 Ac-Tyr-Val-Ala-(RS)-Asp(O^tBu)-H dimethyl acetal 
• 183439-49-8 (RS)-4,4-dimethoxy-3-{[(phenylmethoxy)carbonyl]amino}butanoic acid 1,1-dimethylethyl ester 
• 420135-49-5 (RS)-4-oxo-3-{[(phenylmethoxy)carbonyl]amino}butanoic acid 1,1-dimethylethyl ester 
• 1016258-20-0 (RS)-4-hydroxy-2-{[(phenylmethoxy)carbonyl]amino}butanoic acid 1,1-dimethylethyl ester 

Relevant articles and documents

AMINOBUTANOIC ACID COMPOUNDS HAVING METALLOPROTEASE INHIBITING PROPERTIES

Aminobutanoic acids of the following formula (I): STR1 where R 1-R 5 are a variety of substituents, novel intermediates, a pharmaceutical composition for treating inflammatory diseases, demyelinating diseases, and tumor metastasis, methods for such treatm